ArticleFrontiers in oncology2022

A Multi-Centric Study Assessing Safety and Efficacy of Everolimus in Adult Chinese Patients With Tuberous Sclerosis Complex Associated Renal Angiomyolipomas.

Wenda Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.